Trial intelligence / Profile preview

Tobracort vs Tobradex in Acute Bacterial Conjunctivitis

NCT01227915Phase 3Unknown

Sponsor
Azidus Laboratories Limited
Start
Feb 2011
Primary completion
Feb 2011
Modality
Orthosteric Ligands, RNA-Targeting Small Molecules
Countries
1
01

Overview

A Phase 3 trial of tobramycin + dexamethasone in bacterial conjunctivitis (BC), sponsored by Azidus Laboratories Limited. Status: unknown.

02

Drugs

tobramycin + dexamethasone
03

Conditions

bacterial conjunctivitis (BC)

Beyond the preview

Go deeper on NCT01227915.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01227915.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call